Taiwan - Delayed Quote TWD
Apex Biotechnology Corp. (1733.TW)
32.20
+0.10
+(0.31%)
At close: 1:30:23 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,852,211
1,852,211
1,676,537
2,244,176
2,131,656
Cost of Revenue
1,330,869
1,330,869
1,145,421
1,667,337
1,560,144
Gross Profit
521,342
521,342
531,116
576,839
571,512
Operating Expense
392,833
392,833
387,583
400,279
370,058
Operating Income
128,509
128,509
143,533
176,560
201,454
Net Non Operating Interest Income Expense
-1,578
-1,578
-2,606
-4,821
-12,116
Pretax Income
153,127
153,127
140,962
199,575
184,936
Tax Provision
25,023
25,023
25,248
18,124
-17,353
Net Income Common Stockholders
127,998
127,998
115,783
181,785
202,224
Diluted NI Available to Com Stockholders
127,998
127,998
115,783
181,785
202,224
Basic EPS
1.28
--
1.16
1.82
2.03
Diluted EPS
1.27
--
1.15
1.81
1.93
Basic Average Shares
99,998.44
--
99,812.93
99,950
99,732
Diluted Average Shares
100,785.83
--
100,680.87
100,671
105,637
Total Expenses
1,723,702
1,723,702
1,533,004
2,067,616
1,930,202
Net Income from Continuing & Discontinued Operation
127,998
127,998
115,783
181,785
202,224
Normalized Income
128,035.65
128,035.65
117,274.55
181,785
199,428
Interest Income
2,064
2,064
1,782
577
414
Interest Expense
3,642
3,642
4,388
5,398
12,530
Net Interest Income
-1,578
-1,578
-2,606
-4,821
-12,116
EBIT
156,769
156,769
145,350
204,973
197,466
EBITDA
221,579
221,579
221,060
299,073
293,141
Reconciled Cost of Revenue
1,330,869
1,330,869
1,145,421
1,667,337
1,560,144
Reconciled Depreciation
64,810
64,810
75,710
94,100
95,675
Net Income from Continuing Operation Net Minority Interest
127,998
127,998
115,783
181,785
202,224
Total Unusual Items Excluding Goodwill
-45
-45
-1,817
--
3,495
Total Unusual Items
-45
-45
-1,817
--
3,495
Normalized EBITDA
221,624
221,624
222,877
299,073
289,646
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-7.35
-7.35
-325.45
--
699
12/31/2021 - 6/14/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1734.TW Sinphar Pharmaceutical Co.,Ltd.
31.15
-0.16%
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
28.10
-0.35%
3164.TW GenMont Biotech Incorporation
19.45
+1.04%
4133.TW Abnova (Taiwan) Corporation
27.35
+3.60%
6838.TW Formosa Pharmaceuticals, Inc.
23.40
-1.27%
1760.TW Panion & Bf Biotech Inc.
66.40
+0.15%
4142.TW Adimmune Corporation
18.15
-2.68%
3118.TWO Level Biotechnology Inc.
31.40
0.00%
1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
88.60
-0.45%
6885.TW BRIM Biotechnology, Inc.
22.70
-2.58%